Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026

Same author

Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention.

JACC. Advances·2026

Same author

Trends in 4th-12th grade students' aerobic capacity and muscular strength and endurance: New York City public school students, 2006-2019.

Frontiers in public health·2026

Same author

Impact of right ventricular dysfunction on transcatheter mitral valve implantation outcomes, and subsequent evolution of right ventricular function.

Archives of cardiovascular diseases·2026

Same author

Digital hybrid technique for immediate complete denture fabrication: A clinical report.

Journal of prosthodontics : official journal of the American College of Prosthodontists·2025

Same author

Evaluating waste-derived crude glycerol (CG) as an external carbon source to enhance biological phosphorus removal (BPR) in wastewater treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2025

Search research articles

Related Experiment Video

Updated: May 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

The polypill: a potential global solution to cardiovascular disease.

Caroline Nguyen¹, Angela Cheng-Lai

¹Departments of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Caroline.Nguyen@cshs.org

Cardiology in Review

|September 29, 2012

Summary

The polypill, a single pill combining multiple cardiovascular disease (CVD) medications, offers a promising strategy for global CVD prevention by simplifying treatment and improving adherence, especially in underserved regions. Further research is needed to confirm its safety and efficacy.

Related Experiment Videos

Last Updated: May 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

Cardiology
Public Health
Pharmacology

Background:

Cardiovascular disease (CVD) is a leading global cause of death and disability.
The polypill concept, a single pill with multiple CVD medications, was proposed in 2002 to address this epidemic.
Polypills simplify treatment regimens and enhance medication compliance.

Purpose of the Study:

To examine published and ongoing studies on the polypill.
To outline the advantages and disadvantages of the polypill for global CVD prevention.
To discuss the polypill's design and availability in the United States.

Main Methods:

Review of existing literature on polypill studies.
Analysis of clinical trial data (where available).
Examination of formulation and target population considerations.

Main Results:

The polypill demonstrates promise for CVD prevention.
Potential benefits include simplified healthcare delivery and improved patient adherence.
Limited data currently exist on its safety and efficacy in preventing cardiovascular morbidity and mortality.

Conclusions:

The polypill is a potentially valuable tool for global CVD prevention, particularly in low- and middle-income countries.
Further research is essential to establish its safety, efficacy, and optimal use.
Considerations for target patient populations and formulation are critical for successful implementation.